Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Kula

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 16, 2019
Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin TreatmentsAnna Kula, Nadège Delacourt, Sophie Bouchat, et al.
Molecules (Basel, Switzerland)|October 13, 2021
l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in CellsLuca Sancineto, Carmine Ostacolo, David Ortega-Alarcon, et al.
EMBO Molecular Medicine|December 19, 2015
Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1Sophie Bouchat, Nadège Delacourt, Anna Kula, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2022
Implementation of a Collaborated Antimicrobial Stewardship Program and Outpatient Parenteral Antimicrobial Therapy (OPAT) Unit-driven Monoclonal Antibody Therapy Program for COVID-19 at an NYC HospitalGeorge D Rodriguez, Yuexiu Wu, Krupa Karnik, et al.
Nature Communications|February 28, 2025
Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latencyAgnieszka Dorman, Maryam Bendoumou, Aurelija Valaitienė, et al.
Scientific Reports|October 21, 2024
New insights in the mechanism of the SARS-CoV-2 M<sup>pro</sup> inhibition by benzisoselenazolones and diselenidesLuca Sancineto, Francesca Mangiavacchi, Agnieszka Dabrowska, et al.
Virology Journal|April 28, 2025
Inhibition of ALKBH5 demethylase of m<sup>6</sup>A pathway potentiates HIV-1 reactivation from latencyHaider Ali, Jakub Wadas, Maryam Bendoumou, et al.
Current Medicinal Chemistry|September 6, 2022
Chalcogenium-AZT Derivatives: A Plausible Strategy To Tackle The RT-Inhibitors-Related Oxidative Stress While Maintaining Their Anti- HIV PropertiesJoelma M Sarturi, Luciano Dornelles, Natalia V Segatto, et al.
International Journal of Molecular Sciences|July 2, 2021
Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M<sup>pro</sup> and Its Antiviral Activity in Cells against SARS-CoV-2Francesca Mangiavacchi, Pawel Botwina, Elena Menichetti, et al.
Plos Pathogens|July 31, 2015
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene ExpressionGilles Darcis, Anna Kula, Sophie Bouchat, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 16, 2019
Heterogeneous HIV-1 Reactivation Patterns of Disulfiram and Combined Disulfiram+Romidepsin TreatmentsAnna Kula, Nadège Delacourt, Sophie Bouchat, et al.
Molecules (Basel, Switzerland)|October 13, 2021
l-Arginine Improves Solubility and ANTI SARS-CoV-2 Mpro Activity of Rutin but Not the Antiviral Activity in CellsLuca Sancineto, Carmine Ostacolo, David Ortega-Alarcon, et al.
EMBO Molecular Medicine|December 19, 2015
Sequential treatment with 5-aza-2'-deoxycytidine and deacetylase inhibitors reactivates HIV-1Sophie Bouchat, Nadège Delacourt, Anna Kula, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 6, 2022
Implementation of a Collaborated Antimicrobial Stewardship Program and Outpatient Parenteral Antimicrobial Therapy (OPAT) Unit-driven Monoclonal Antibody Therapy Program for COVID-19 at an NYC HospitalGeorge D Rodriguez, Yuexiu Wu, Krupa Karnik, et al.
Nature Communications|February 28, 2025
Nuclear retention of unspliced HIV-1 RNA as a reversible post-transcriptional block in latencyAgnieszka Dorman, Maryam Bendoumou, Aurelija Valaitienė, et al.
Scientific Reports|October 21, 2024
New insights in the mechanism of the SARS-CoV-2 M<sup>pro</sup> inhibition by benzisoselenazolones and diselenidesLuca Sancineto, Francesca Mangiavacchi, Agnieszka Dabrowska, et al.
Virology Journal|April 28, 2025
Inhibition of ALKBH5 demethylase of m<sup>6</sup>A pathway potentiates HIV-1 reactivation from latencyHaider Ali, Jakub Wadas, Maryam Bendoumou, et al.
Current Medicinal Chemistry|September 6, 2022
Chalcogenium-AZT Derivatives: A Plausible Strategy To Tackle The RT-Inhibitors-Related Oxidative Stress While Maintaining Their Anti- HIV PropertiesJoelma M Sarturi, Luciano Dornelles, Natalia V Segatto, et al.
International Journal of Molecular Sciences|July 2, 2021
Seleno-Functionalization of Quercetin Improves the Non-Covalent Inhibition of M<sup>pro</sup> and Its Antiviral Activity in Cells against SARS-CoV-2Francesca Mangiavacchi, Pawel Botwina, Elena Menichetti, et al.
Plos Pathogens|July 31, 2015
An In-Depth Comparison of Latency-Reversing Agent Combinations in Various In Vitro and Ex Vivo HIV-1 Latency Models Identified Bryostatin-1+JQ1 and Ingenol-B+JQ1 to Potently Reactivate Viral Gene ExpressionGilles Darcis, Anna Kula, Sophie Bouchat, et al.
Pageof 4